COPD Trial, Recruiting (NCT06847061)

COPD Trial, Recruiting NCT06847061 Sponsor: Mayo Clinic Condition: COPD

Printed from Voxsanity (voxsanity.com.au) — NCT06847061 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Copd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are 40 years of age or older
People who have been diagnosed with COPD by a doctor
People who live in a rural area, as defined by Rural-Urban Commuting Area codes 4 through 10 (confirm with trial site if unsure about your area's classification)
People who have a breathlessness score of 1 or higher on a standard scale called the mMRC scale, meaning at least some shortness of breath in daily life
People who speak English

Who may not be able to join:

People who are unable to walk due to a bone, nerve, or heart condition that causes immobility
People who have cognitive impairment or difficulty understanding and following instructions
People who have no COPD symptom burden and no breathlessness (an mMRC score of 0)
People who completed a traditional, centre-based pulmonary rehabilitation program within 3 months before joining the study
People who are receiving hospice or end-of-life care at the time of screening
People who are experiencing an acute flare-up (sudden worsening) of their COPD at the time of screening

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 14 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Roberto Benzo, M.D., Mayo Clinic

Phone: 507-293-1989

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06847061

Sponsor: Mayo Clinic

Phase: Not Applicable

Status: Recruiting

Condition: COPD

Trial contact: 507-293-1989

More information: https://clinicaltrials.gov/study/NCT06847061

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are 40 years of age or older
People who have been diagnosed with COPD by a doctor
People who live in a rural area, as defined by Rural-Urban Commuting Area codes 4 through 10 (confirm with trial site if unsure about your area's classification)
People who have a breathlessness score of 1 or higher on a standard scale called the mMRC scale, meaning at least some shortness of breath in daily life
People who speak English

Who may not be able to join:

People who are unable to walk due to a bone, nerve, or heart condition that causes immobility
People who have cognitive impairment or difficulty understanding and following instructions
People who have no COPD symptom burden and no breathlessness (an mMRC score of 0)
People who completed a traditional, centre-based pulmonary rehabilitation program within 3 months before joining the study
People who are receiving hospice or end-of-life care at the time of screening
People who are experiencing an acute flare-up (sudden worsening) of their COPD at the time of screening

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 14 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Mayo Clinic

Registry

ClinicalTrials.gov

Start date

1 April 2025

Est. completion

31 August 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change Chronic Respiratory Questionnaire Physical and Emotional (CRQ-SAS) summary scores

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov